Advances in biomarker development and potential application for preeclampsia based on pathogenesis
Preeclampsia (PE) is a pregnancy-specific complication that seriously threatens the health and safety of mothers and infants. The etiology of PE has not been fully elucidated, and no effective treatments are currently available. A pregnant woman with PE often has to make a tough choice on either end...
Saved in:
Main Authors: | Nan Liu (Author), Yu-Na Guo (Author), Li-Kun Gong (Author), Bing-Shun Wang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Recent advances in the pathogenesis and potential biomarkers of fibrosis
by: Samar A. Antar, et al.
Published: (2024) -
Pathogenesis of Preeclampsia: The Genetic Component
by: Francisco J. Valenzuela, et al.
Published: (2012) -
The Role of Inflammation in the Pathogenesis of Preeclampsia
by: Michał Michalczyk, et al.
Published: (2020) -
Diagnosis of preeclampsia using metabolomic biomarkers
by: Yunfan Tian, et al.
Published: (2024) -
An Update Review of the Pathogenesis Hypothesis in Preeclampsia
by: Rui Lian, et al.
Published: (2022)